BRIEF-Avenue therapeutics reports Q2 loss per share $0.70
Aug 11 (Reuters) - Avenue Therapeutics Inc
* Avenue Therapeutics reports second quarter 2017 financial results and recent corporate highlights
* Q2 loss per share $0.70 Source text for Eikon: Further company coverage: